F. Salvà

发表

Cost-minimisation analysis of rectal cancer neoadjuvant chemoradiotherapy based on fluoropyrimidines (capecitabine versus 5-fluorouracil)

P. Lianes, L. Campins, S. Marin, 2020, European journal of hospital pharmacy : science and practice.

Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer

J. Tabernero, E. Elez, I. Baraibar, 2022, Therapeutic advances in gastroenterology.

LBA-3 Integrated analysis of cell-free DNA (cfDNA) BRAF mutant allele fraction (MAF) and whole exome sequencing in BRAFV600E metastatic colorectal cancer (mCRC) treated with BRAF-antiEGFR +/- MEK inhibitors

P. Nuciforo, J. Tabernero, F. Ciardiello, 2021, Annals of Oncology.

Pharmacokinetics and pharmacodynamics of approved monoclonal antibody therapy for colorectal cancer

J. Tabernero, I. Baraibar, J. Ros, 2022, Expert opinion on drug metabolism & toxicology.

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer

J. Tabernero, R. Dienstmann, G. Martini, 2020, Therapeutic advances in medical oncology.

Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer

J. Tabernero, O. Mirallas, I. Baraibar, 2021, Cancers.

Ongoing and evolving clinical trials enhancing future colorectal cancer treatment strategies

J. Tabernero, I. Baraibar, J. Ros, 2022, Expert opinion on investigational drugs.

BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer

J. Tabernero, G. Martini, D. Ciardiello, 2021, Therapeutic advances in medical oncology.

Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update

J. Tabernero, G. Martini, D. Ciardiello, 2020, Expert review of molecular diagnostics.

Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer

J. Tabernero, I. Baraibar, J. Ros, 2023, Frontiers in Oncology.

The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer

J. Tabernero, R. Dienstmann, G. Martini, 2021, Current Treatment Options in Oncology.

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy

R. Salazar, J. Tabernero, P. Nuciforo, 2022, International journal of molecular sciences.

EGFR Amplification in Metastatic Colorectal Cancer.

A. Bardelli, R. Yaeger, J. Hechtman, 2021, Journal of the National Cancer Institute.

Liver transplantation in metastatic colorectal cancer: are we ready for it?

J. Tabernero, I. Baraibar, C. Dopazo, 2023, British Journal of Cancer.

Impact of the COVID-19 pandemic in the early-onset colorectal cancer

P. Nuciforo, J. Tabernero, S. Landolfi, 2023, Translational Oncology.

Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.

G. Martini, E. Martinelli, F. Pietrantonio, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

Sex and gender perspectives in colorectal cancer

I. Baraibar, J. Ros, J. Tabernero, 2023, ESMO open.

Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.

E. Felip, F. Salvà, 2013, Translational lung cancer research.

Concordance of PD-L1 expression by different immunohistochemistry (IHC) definitions and in situ hybridization (ISH) in squamous cell carcinoma (SCC) of the lung.

E. Felip, S. Cedrés, P. Nuciforo, 2014 .

Up-to-date role of aflibercept in the treatment of colorectal cancer

J. Tabernero, I. Baraibar, J. Ros, 2021, Expert opinion on biological therapy.

Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications

J. Tabernero, I. Baraibar, J. Ros, 2023, Cancers.

Treatment of BRAF-V600E mutant metastatic colorectal cancer: new insights and biomarkers

J. Tabernero, I. Baraibar, J. Ros, 2023, Expert review of anticancer therapy.

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers

J. Tabernero, M. Rodríguez, I. Baraibar, 2023, Cancers.

The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey

I. Baraibar, J. Ros, F. Salvà, 2023, Frontiers in oncology.

The role of pro‐, pre‐ and symbiotics in cancer: A systematic review

M. Miarons, F. Salvà, Maria Roca, 2020 .

Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer

I. Baraibar, J. Ros, Ariadna García, 2024, International journal of molecular sciences.

Determinants of metastatic colorectal cancer with permanent liver- limited disease

I. Baraibar, J. Ros, Ariadna García, 2024, Clinical Colorectal Cancer.

Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer

I. Baraibar, J. Ros, Ariadna García, 2024, Cancers.